Amgen | AMGN

Stock Price
344.71
Daily Change
2.83 0.83%
Monthly
7.48%
Yearly
19.33%
Q1 Forecast
331.35



Peers Price Chg Day Year Date
Takeda 5,419.00 77.00 1.44% 31.02% Feb/03
AbbVie 225.64 2.63 1.18% 18.67% Feb/02
Agios Pharmaceuticals 28.16 0.72 2.62% -16.23% Feb/02
ALKERMES 34.96 1.07 3.16% 13.65% Feb/02
Amgen 344.71 2.83 0.83% 19.33% Feb/02
Biogen 179.09 -0.80 -0.44% 25.82% Feb/02
BioMarin Pharmaceutical 57.95 1.41 2.49% -7.19% Feb/02
Bristol-Myers Squibb 55.89 0.84 1.53% -6.77% Feb/02
Exelixis 42.81 1.45 3.51% 30.20% Feb/02
Genmab 2,088.00 -2.00 -0.10% 49.84% Feb/03

Indexes Price Day Year Date
US500 7001 37.41 0.54% 15.94% Feb/03
USND 23592 130.29 0.56% 21.66% Feb/02
US30 49472 515.19 1.05% 11.03% Feb/03
US100 25894 186.22 0.73% 20.06% Feb/03

Amgen traded at $344.71 this Monday February 2nd, increasing $2.83 or 0.83 percent since the previous trading session. Looking back, over the last four weeks, Amgen gained 7.48 percent. Over the last 12 months, its price rose by 19.33 percent. Looking ahead, we forecast Amgen to be priced at 331.35 by the end of this quarter and at 301.67 in one year, according to Trading Economics global macro models projections and analysts expectations.

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine) and AVSOLA (infliximab-axxq). It focuses on human therapeutics for the treatment of serious illness in the areas of inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience.



News Stream
Amgen Stock Price Hits 6-week High
Amgen shares increased to 343.05 USD, the highest since December 2025. Over the past 4 weeks, Amgen gained 3.47%, and in the last 12 months, it increased 25.39%.
2026-01-21
Amgen Stock Price Hits 4-week High
Amgen shares increased to 335.43 USD, the highest since December 2025. Over the past 4 weeks, Amgen gained 2.78%, and in the last 12 months, it increased 25.99%.
2026-01-07
Amgen Stock Price Hits 4-week Low
Amgen shares decreased to 323.28 USD, the lowest since November 2025. Over the past 4 weeks, Amgen lost 0.07%, and in the last 12 months, it increased 16.47%.
2025-12-08